Topical timolol 0.5% gel-forming solution for erythema in rosacea: A quantitative, split-face, randomized, and rater-masked pilot clinical trial

J Am Acad Dermatol. 2021 Oct;85(4):1044-1046. doi: 10.1016/j.jaad.2021.01.098. Epub 2021 Feb 3.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Double-Blind Method
  • Erythema / drug therapy
  • Gels
  • Humans
  • Research Design
  • Rosacea* / drug therapy
  • Timolol*
  • Treatment Outcome

Substances

  • Gels
  • Timolol